Prediction of Adverse Events From Non-PCI Coronary Plaques Using Machine Learning
Predict AI
Predict AI
Sponsor study identifier
observational
600
1 country
1
Study Start
January 1, 2023
Actual (reported)Primary Completion
July 1, 2026
Actual (reported)Study Completion
July 1, 2026
Actual (reported)The aim of our project is to predict, with the help of artificial intelligence (AI) and machine learning techniques, the natural history of non-flow-limiting coronary stenoses and to develop and validate a machine learning risk score able to estimate the risk of MACE during follow-up based on OCT findings observed on coronary plaques not subjected to percutaneous coronary intervention (PCI) and on the clinical characteristics of the patients. We will collect information on all non-PCI coronary lesions assessed by performing OCT in non-culprit vessels of patients presenting with ACS or Chronic Coronary Syndrome (CCS) at the index procedure. All OCT runs will be digitized and analyzed with the help of AI. The OCT appearance of coronary plaques will be analyzed with AI and correlated with the risk of MACE during follow-up (a composite of cardiac death, myocardial infarction, or target lesion revascularization). An AI predictive risk model based on coronary plaque OCT images and patient clinical characteristics will be developed to estimate the risk of MACE incidence at follow-up. Cutting-edge machine learning algorithms, including convolutional neural networks, random forests, and support vector machines, will be used.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 1, 2026
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2023
Actual (reported)July 1, 2026
Actual (reported)July 1, 2026
Actual (reported)October 5, 2026
Actual (reported)October 8, 2026
Actual (reported)MACE
Composite end point of all cause death, MI, urgent revascularization and TVR
12 months
MACCE
composite end point of CV death, MI, urgent revascularization and TVR
12 months
Men and women over 18 years of age, presenting with STEMI - NSTEMI - CCS - UA.
AOU Città della Salute e della Scienza
Turin, Italy, 10126, Italy
600 participants (actual enrollment reported by the registry).
First Submitted
October 5, 2026
First Posted
October 8, 2026
Study Start
January 1, 2023
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
July 1, 2026
Actual (reported)Study Completion
July 1, 2026
Actual (reported)Last Updated
October 8, 2026
Record last verified: 2026-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: